Evidence map›Paper›PMID 37465762›Full record

ArticleFrontiers in cellular and infection microbiology2023

Ratio of procalcitonin/Simpson's dominance index predicted the short-term prognosis of patients with severe bacterial pneumonia.

Guoxian Sun, Weili Liu, Qingbin Zheng, Qing Shan, Hongling Hou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Guoxian SunDepartment of Infection Control, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Weili LiuDepartment of Critical Care Unit, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Qingbin ZhengDepartment of Critical Care Unit, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Qing ShanDepartment of Infection Control, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Hongling HouDepartment of Neurology, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Yangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study was to explore the predictive value of the ratio of procalcitonin (PCT) in serum to Simpson's dominance index (SDI) in bronchoalveolar lavage fluid (BALF), in short-term prognosis of patients with severe bacterial pneumonia (SBP). Methods: This is a retrospective review of case materials of 110 patients with SBP who selected BALF metagenomic next-generation sequencing technique in the intensive care unit (ICU) of the Affiliated Hospital of Yangzhou University from January 2019 and July 2022. Based on the acute physiology and chronic health status score II, within 24 h after admission to the ICU, patients were divided into a non-critical group ( Results: Compared with the non-critical group, the critical group had a higher PCT level, a greater PCT/SDI ratio, a longer ventilator-assisted ventilation time (VAVT), and more deaths in 28 days. Compared with the survivors, the death group had a higher PCT level, a lower SDI level, and a greater PCT/SDI ratio. The SDI level was significantly negatively correlated with the VAVT ( Conclusion: The ratio of PCT/SDI was a more valuable marker in predicting the 28-day prognosis in patients with SBP.

Indexed as

Pneumonia, BacterialSepsisC-Reactive ProteinHumansProcalcitoninRetrospective StudiesSensitivity and SpecificityC-Reactive ProteinProcalcitoninbacterial pneumoniabronchoalveolar lavage fluidpredictiveprocalcitoninSimpson’s dominance index

Identifiers

PMID37465762
PMCPMC10350521
OpenAlexW4382982278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.